Skip to main content
OpenTrials
Completed

NCT Number: NCT04461626

Prospective Multi-centre Outcomes Study of Persona Knee System in Total Knee Arthroplasty

This is a prospective, multi-centre, non comparative, post market clinical follow-up study involving orthopaedic surgeons skilled in TKA and experienced implanting the devices included in this study.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Fremantle Hospital, West Perth, Australia

Loading trial locations.

About this study

The objectives of the study are to document the implant survivorship and clinical outcomes data for the Persona fixed bearing implants used in primary total knee arthroplasty (TKA). The study will include a maximum of 20 centres and up to 1000 implanted knees. Each centre may enrol up to a maximum of 100 implanted knees to permit assessment of the consistency of outcomes across a variety of investigators and clinical settings.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 18 to 80 years old, inclusive
  • Qualifies for a primary TKA based on physical exam and medical history, including diagnosis of severe knee pain and disability due to at least one of the following:
  • Rheumatoid arthritis, osteoarthritis, traumatic arthritis, polyarthritis.
  • Collagen disorders and/ or avascular necrosis of femoral condyle.
  • Post-traumatic loss of joint configuration, particularly when there is patellofemoral erosion, dysfunction or prior patellectomy.
  • Moderate valgus, varus or flexion deformities.
  • The salvage of previously failed surgical attempts that did not include partial or total knee arthroplasty of the ipsilateral knee.
  • Participated in a study-related informed consent process.
  • Willing and able to provide written informed consent by signing and dating the IRB/EC approved informed consent form.
  • Willing and able to complete scheduled study procedures and follow-up evaluations.
  • Independent of study participation, patient is a candidate for commercially available Persona fixed bearing knee system implanted in accordance with product labelling.

Exclusion criteria

  • Currently participating in any other surgical intervention studies or pain management studies.
  • Previous history of infection in the affected joint and/or other local/systemic infection that may affect the prosthetic joint.
  • Insufficient bone stock on femoral or tibial surfaces/
  • Skeletal immaturity
  • Neuropathic arthropathy
  • Any loss of musculature or neuromuscular disease that compromises the affected limb.
  • Stable, painless arthrodesis in a satisfactory functional position.
  • Severe instability secondary to the absence of collateral ligament integrity.
  • Rheumatoid arthritis accompanied by an ulcer of the skin or a history of recurrent breakdown of the skin.
  • Known or suspected sensitivity or allergy to one or more of the implant materials.
  • Pregnant or considered a member of a protected population (e.g. prisoner, mentally incompetent, etc.)
  • Previously received partial or total knee arthroplasty for the ipsilateral knee.

Treatment and study plan

Persona fixed bearing knee system (All patients will receive Persona fixed bearing knee system)

Device

Primary outcomes

  1. Implant Survivorship

    Time frame: Up to 5 years post surgery

    Implant survivorship based on removal of the study device and will be summarized using Kaplan-Meier analysis

  2. Adverse Events (Safety)

    Time frame: Up to 5 years post surgery

    Safety based on incidence and frequency of adverse events

  3. Clinical Performance

    Time frame: Up to 5 years post surgery

    Clinical Performance measured by overall pain and function and qualify of life Measured using EQ5D questionnaire and Knee Society Score

  4. Clinical Performance

    Time frame: Up to 5 years post surgery

    Clinical Performance measured by physician assessment of radiographs form. Data collected include the position and assessment of the radiographs of the operated knee

Sponsors and collaborators

Lead sponsor

Zimmer Biomet

Industry

Registry information

Important dates

Study start
2014
Primary completion
2023
Study completion
2024
First posted
Jul 8, 2020
Registry last updated
Aug 22, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.